These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25896426)

  • 41. Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants.
    Lyauk YK; Stage C; Bergmann TK; Ferrero-Milliani L; Bjerre D; Thomsen R; Dalhoff KP; Rasmussen HB; Jürgens G
    Clin Transl Sci; 2016 Dec; 9(6):337-345. PubMed ID: 27754602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
    Xu EY; Schaefer WH; Xu Q
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overview of in vitro metabolism of drugs by aquatic species.
    James MO
    Vet Hum Toxicol; 1986; 28 Suppl 1():2-8. PubMed ID: 3151420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A near-infrared fluorescent probe based on a hemi-cyanine skeleton for detecting CES1 activity and evaluating pesticide toxicity.
    Zhao X; Tian M; Wang Y; Yang F; Liang G; Tian X; Feng L; Cui J
    J Mater Chem B; 2023 Apr; 11(16):3587-3591. PubMed ID: 37071077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct patterns of aging effects on the expression and activity of carboxylesterases in rat liver and intestine.
    Ohura K; Tasaka K; Hashimoto M; Imai T
    Drug Metab Dispos; 2014 Feb; 42(2):264-73. PubMed ID: 24271336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver.
    Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T
    Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans.
    Tarkiainen EK; Holmberg MT; Tornio A; Neuvonen M; Neuvonen PJ; Backman JT; Niemi M
    Clin Pharmacol Ther; 2015 Jun; 97(6):650-8. PubMed ID: 25704243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy.
    Quinn RA; Nothias LF; Vining O; Meehan M; Esquenazi E; Dorrestein PC
    Trends Pharmacol Sci; 2017 Feb; 38(2):143-154. PubMed ID: 27842887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide identification of structural variants in genes encoding drug targets: possible implications for individualized drug therapy.
    Rasmussen HB; Dahmcke CM
    Pharmacogenet Genomics; 2012 Jul; 22(7):471-83. PubMed ID: 22466257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure, function and regulation of carboxylesterases.
    Satoh T; Hosokawa M
    Chem Biol Interact; 2006 Sep; 162(3):195-211. PubMed ID: 16919614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
    Nishimuta H; Houston JB; Galetin A
    Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [ Proceedings: Microsomal hydrolases and drug metabolism].
    Krisch K
    Z Klin Chem Klin Biochem; 1975 Aug; 13(8):371. PubMed ID: 1216965
    [No Abstract]   [Full Text] [Related]  

  • 54. Metabolite profiling in early clinical drug development: current status and future prospects.
    Ufer M; Juif PE; Boof ML; Muehlan C; Dingemanse J
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):803-806. PubMed ID: 28689432
    [No Abstract]   [Full Text] [Related]  

  • 55. Systematic identification and characterization of carboxylesterases in cynomolgus macaques.
    Uno Y; Uehara S; Hosokawa M; Imai T
    Drug Metab Dispos; 2014 Dec; 42(12):2002-6. PubMed ID: 25256558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
    Ishizuka T; Yoshigae Y; Murayama N; Izumi T
    Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
    Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
    Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human carboxylesterases in term placentae: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms.
    Yan B; Matoney L; Yang D
    Placenta; 1999 Sep; 20(7):599-607. PubMed ID: 10452915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-Ibuprofen.
    Mattheolabakis G; Wong CC; Sun Y; Amella CA; Richards R; Constantinides PP; Rigas B
    J Pharmacol Exp Ther; 2014 Oct; 351(1):61-6. PubMed ID: 25047517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolomics: a global biochemical approach to drug response and disease.
    Kaddurah-Daouk R; Kristal BS; Weinshilboum RM
    Annu Rev Pharmacol Toxicol; 2008; 48():653-83. PubMed ID: 18184107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.